Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $661.44 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $323.52 | 18 | $0 (2024) |
| PFIZER INC. | $170.20 | 11 | $0 (2024) |
| Allergan, Inc. | $49.99 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $33.55 | 2 | $0 (2024) |
| Baxter Healthcare | $32.43 | 1 | $0 (2024) |
| Amgen Inc. | $21.40 | 1 | $0 (2022) |
| Biogen, Inc. | $18.39 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $11.96 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $420.13 | 24 | ABBVIE INC. ($201.82) |
| 2023 | $64.60 | 4 | ABBVIE INC. ($46.73) |
| 2022 | $146.36 | 7 | ABBVIE INC. ($74.97) |
| 2018 | $11.96 | 1 | Sunovion Pharmaceuticals Inc. ($11.96) |
| 2017 | $18.39 | 1 | Biogen, Inc. ($18.39) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PAIN | ||||||
| 09/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: PAIN | ||||||
| 09/11/2024 | Baxter Healthcare | PREVELEAK (Device) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Surgical Care | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: PAIN | ||||||
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: PAIN | ||||||
| 08/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PAIN | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Neurology | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PAIN | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: PAIN | ||||||
| 03/06/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Neurology | ||||||
| 02/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: PAIN | ||||||
| 02/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: PAIN | ||||||
| 01/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PAIN | ||||||
| 12/07/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 607 | 748 | $160,642 | $77,952 |
| 2022 | 6 | 574 | 684 | $163,050 | $80,425 |
| 2021 | 8 | 761 | 999 | $230,110 | $129,330 |
| 2020 | 13 | 770 | 1,012 | $214,726 | $109,885 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 229 | $43,739 | $20,446 | 46.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 115 | 117 | $36,153 | $16,741 | 46.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 95 | 143 | $25,146 | $13,699 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $13,462 | $5,996 | 44.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 49 | $10,339 | $5,579 | 54.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 33 | 42 | $11,382 | $4,767 | 41.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 64 | $7,302 | $4,345 | 59.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $5,661 | $2,449 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 17 | $4,607 | $2,272 | 49.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $2,851 | $1,658 | 58.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 104 | 107 | $33,063 | $18,385 | 55.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 166 | $26,752 | $14,325 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 122 | $22,906 | $10,864 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $25,654 | $10,808 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 59 | $15,590 | $8,298 | 53.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 49 | 49 | $16,155 | $7,327 | 45.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $9,459 | $4,695 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 30 | 36 | $9,661 | $4,164 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $3,810 | $1,559 | 40.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 238 | 247 | $76,323 | $45,923 | 60.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 211 | 416 | $65,728 | $38,634 | 58.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 76 | 76 | $19,304 | $10,026 | 51.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 47 | 47 | $14,805 | $6,972 | 47.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $12,285 | $6,741 | 54.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 14 | 28 | $11,788 | $4,949 | 42.0% |
About Alejandro Hornik
Alejandro Hornik is a Neurology healthcare provider based in Herrin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134384977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alejandro Hornik has received a total of $661.44 in payments from pharmaceutical and medical device companies, with $420.13 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($661.44).
As a Medicare-enrolled provider, Hornik has provided services to 2,712 Medicare beneficiaries, totaling 3,443 services with total Medicare billing of $397,591. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Herrin, IL
- Active Since 07/21/2008
- Last Updated 05/06/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1134384977
Products in Payments
- BOTOX (Biological) $278.06
- NURTEC ODT (Drug) $170.20
- QULIPTA (Drug) $50.96
- UBRELVY (Drug) $44.49
- KESIMPTA (Drug) $33.55
- PREVELEAK (Device) $32.43
- Aimovig (Biological) $21.40
- TECFIDERA (Drug) $18.39
- APTIOM (Drug) $11.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.